Literature DB >> 22158218

Novartis to shut brain research facility.

Alison Abbott.   

Abstract

Mesh：

Year:  2011        PMID： 22158218     DOI： 10.1038/480161a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  21 in total

Review 1.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

Review 2.  Seven challenges for neuroscience.

Authors:  Henry Markram
Journal:  Funct Neurol       Date:  2013 Jul-Sep

Review 3.  Newer antipsychotics and upcoming molecules for schizophrenia.

Authors:  Melvin George; Radhika Amrutheshwar; Ravi Philip Rajkumar; Shivanand Kattimani; Steven Aibor Dkhar
Journal:  Eur J Clin Pharmacol       Date:  2013-04-02       Impact factor: 2.953

4.  Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications.

Authors:  Islam R Younis; Mathangi Gopalakrishnan; Mitchell Mathis; Mehul Mehta; Ramana Uppoor; Hao Zhu; Tiffany Farchione
Journal:  JAMA Psychiatry       Date:  2020-10-01       Impact factor: 21.596

Review 5.  Improving and accelerating drug development for nervous system disorders.

Authors:  Diana E Pankevich; Bruce M Altevogt; John Dunlop; Fred H Gage; Steve E Hyman
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

Review 6.  The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.

Authors:  Valentin K Gribkoff; Leonard K Kaczmarek
Journal:  Neuropharmacology       Date:  2016-03-12       Impact factor: 5.250

Review 7.  Anxioselective anxiolytics: on a quest for the Holy Grail.

Authors:  Phil Skolnick
Journal:  Trends Pharmacol Sci       Date:  2012-09-14       Impact factor: 14.819

Review 8.  Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.

Authors:  Andra Mihali; Shreya Subramani; Genevieve Kaunitz; Stephen Rayport; Inna Gaisler-Salomon
Journal:  Expert Rev Neurother       Date:  2012-07       Impact factor: 4.618

Review 9.  Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview.

Authors:  Ekram Ahmed Chowdhury; Behnam Noorani; Faleh Alqahtani; Aditya Bhalerao; Snehal Raut; Farzane Sivandzade; Luca Cucullo
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

Review 10.  Circuit dynamics of adaptive and maladaptive behaviour.

Authors:  Karl Deisseroth
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.